These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 28166815)

  • 1. Regulation of submaxillary gland androgen-regulated protein 3A via estrogen receptor 2 in radioresistant head and neck squamous cell carcinoma cells.
    Grünow J; Rong C; Hischmann J; Zaoui K; Flechtenmacher C; Weber KJ; Plinkert P; Hess J
    J Exp Clin Cancer Res; 2017 Feb; 36(1):25. PubMed ID: 28166815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conjoint analysis of OPRPN and SMR3A protein expression as potential predictive biomarkers for head and neck squamous cell carcinoma after radiotherapy.
    Rong C; Grünow J; Thierauf J; Lucena-Porcel C; Major G; Holzinger D; Dyckhoff G; Kern J; Lammert A; Scherl C; Rotter N; Plinkert PK; Affolter A
    Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35856431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Submaxillary Gland Androgen-regulated Protein 3A (SMR3A) in Adenoid Cystic Carcinoma of the Head and Neck.
    Thierauf J; Veit JA; Grünow J; Döscher J; Weißinger S; Whiteside T; Beutner D; Quaas A; Plinkert P; Hoffmann TK; Hess J
    Anticancer Res; 2016 Feb; 36(2):611-5. PubMed ID: 26851015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Submaxillary gland androgen-regulated protein 3A expression is an unfavorable risk factor for the survival of oropharyngeal squamous cell carcinoma patients after surgery.
    Koffler J; Holzinger D; Sanhueza GA; Flechtenmacher C; Zaoui K; Lahrmann B; Grabe N; Plinkert PK; Hess J
    Eur Arch Otorhinolaryngol; 2013 Mar; 270(4):1493-500. PubMed ID: 23053383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioresistant head and neck squamous cell carcinoma cells: intracellular signaling, putative biomarkers for tumor recurrences and possible therapeutic targets.
    Skvortsov S; Jimenez CR; Knol JC; Eichberger P; Schiestl B; Debbage P; Skvortsova I; Lukas P
    Radiother Oncol; 2011 Oct; 101(1):177-82. PubMed ID: 21700351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.
    Yun M; Choi AJ; Lee YC; Kong M; Sung JY; Kim SS; Eun YG
    J Exp Clin Cancer Res; 2018 Oct; 37(1):264. PubMed ID: 30376862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients.
    Schrader CH; Kolb M; Zaoui K; Flechtenmacher C; Grabe N; Weber KJ; Hielscher T; Plinkert PK; Hess J
    Mol Cancer; 2015 May; 14():107. PubMed ID: 25990935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic amplification of Fanconi anemia complementation group A (FancA) in head and neck squamous cell carcinoma (HNSCC): Cellular mechanisms of radioresistance and clinical relevance.
    Hess J; Unger K; Orth M; Schötz U; Schüttrumpf L; Zangen V; Gimenez-Aznar I; Michna A; Schneider L; Stamp R; Selmansberger M; Braselmann H; Hieber L; Drexler GA; Kuger S; Klein D; Jendrossek V; Friedl AA; Belka C; Zitzelsberger H; Lauber K
    Cancer Lett; 2017 Feb; 386():87-99. PubMed ID: 27867017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glyoxalase 1 expression is associated with an unfavorable prognosis of oropharyngeal squamous cell carcinoma.
    Kreycy N; Gotzian C; Fleming T; Flechtenmacher C; Grabe N; Plinkert P; Hess J; Zaoui K
    BMC Cancer; 2017 May; 17(1):382. PubMed ID: 28549423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV Protease Inhibitors Sensitize Human Head and Neck Squamous Carcinoma Cells to Radiation by Activating Endoplasmic Reticulum Stress.
    Liu R; Zhang L; Yang J; Zhang X; Mikkelsen R; Song S; Zhou H
    PLoS One; 2015; 10(5):e0125928. PubMed ID: 25933118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes.
    Foy JP; Bazire L; Ortiz-Cuaran S; Deneuve S; Kielbassa J; Thomas E; Viari A; Puisieux A; Goudot P; Bertolus C; Foray N; Kirova Y; Verrelle P; Saintigny P
    BMC Med; 2017 Sep; 15(1):165. PubMed ID: 28859688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of SOX2 expression induces cell motility via vimentin up-regulation and is an unfavorable risk factor for survival of head and neck squamous cell carcinoma.
    Bayo P; Jou A; Stenzinger A; Shao C; Gross M; Jensen A; Grabe N; Mende CH; Rados PV; Debus J; Weichert W; Plinkert PK; Lichter P; Freier K; Hess J
    Mol Oncol; 2015 Oct; 9(8):1704-19. PubMed ID: 26040981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of different response to ionizing irradiation in isogenic head and neck cancer cell lines.
    Todorovic V; Prevc A; Zakelj MN; Savarin M; Brozic A; Groselj B; Strojan P; Cemazar M; Sersa G
    Radiat Oncol; 2019 Nov; 14(1):214. PubMed ID: 31775835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taselisib (GDC-0032), a Potent β-Sparing Small Molecule Inhibitor of PI3K, Radiosensitizes Head and Neck Squamous Carcinomas Containing Activating PIK3CA Alterations.
    Zumsteg ZS; Morse N; Krigsfeld G; Gupta G; Higginson DS; Lee NY; Morris L; Ganly I; Shiao SL; Powell SN; Chung CH; Scaltriti M; Baselga J
    Clin Cancer Res; 2016 Apr; 22(8):2009-19. PubMed ID: 26589432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses.
    You GR; Cheng AJ; Lee LY; Huang YC; Liu H; Chen YJ; Chang JT
    BMC Cancer; 2019 Jan; 19(1):64. PubMed ID: 30642292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients.
    Pavón MA; Arroyo-Solera I; Téllez-Gabriel M; León X; Virós D; López M; Gallardo A; Céspedes MV; Casanova I; López-Pousa A; Mangues MA; Quer M; Barnadas A; Mangues R
    Oncotarget; 2015 Oct; 6(30):29016-33. PubMed ID: 26359694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor variant III in head and neck squamous cell carcinoma is not relevant for targeted therapy and irradiation.
    Thomas Koch D; Pickhard A; Gebel L; Buchberger AMS; Bas M; Mogler C; Reiter R; Piontek G; Wirth M
    Oncotarget; 2017 May; 8(20):32668-32682. PubMed ID: 28427242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERCC1 protein expression is associated with differential survival in oropharyngeal head and neck squamous cell carcinoma.
    Patel MR; Zhao N; Ang MK; Stadler ME; Fritchie K; Weissler MC; Zanation AM; Harris SL; Funkhouser WK; Olshan AF; Shores CG; Hayes DN
    Otolaryngol Head Neck Surg; 2013 Oct; 149(4):587-95. PubMed ID: 23846458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of salinomycin and radiation effectively eliminates head and neck squamous cell carcinoma cells in vitro.
    Gehrke T; Hackenberg S; Polat B; Wohlleben G; Hagen R; Kleinsasser N; Scherzad A
    Oncol Rep; 2018 Apr; 39(4):1991-1998. PubMed ID: 29436675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced radiosensitivity of head and neck squamous cell carcinoma cells by β1 integrin inhibition.
    Eke I; Dickreuter E; Cordes N
    Radiother Oncol; 2012 Aug; 104(2):235-42. PubMed ID: 22748391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.